These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12619033)

  • 21. c-Jun NH2-terminal kinase-dependent Fas activation contributes to etoposide-induced apoptosis in p53-mutated prostate cancer cells.
    Shimada K; Nakamura M; Ishida E; Kishi M; Yonehara S; Konishi N
    Prostate; 2003 Jun; 55(4):265-80. PubMed ID: 12712406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis.
    Saeki K; Kobayashi N; Inazawa Y; Zhang H; Nishitoh H; Ichijo H; Saeki K; Isemura M; Yuo A
    Biochem J; 2002 Dec; 368(Pt 3):705-20. PubMed ID: 12206715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antagonistic effects of sodium butyrate and N-(4-hydroxyphenyl)-retinamide on prostate cancer.
    Kuefer R; Genze F; Zugmaier W; Hautmann RE; Rinnab L; Gschwend JE; Angelmeier M; Estrada A; Buechele B
    Neoplasia; 2007 Mar; 9(3):246-53. PubMed ID: 17401464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cisplatin-induced response of c-jun N-terminal kinase 1 and extracellular signal--regulated protein kinases 1 and 2 in a series of cisplatin-resistant ovarian carcinoma cell lines.
    Cui W; Yazlovitskaya EM; Mayo MS; Pelling JC; Persons DL
    Mol Carcinog; 2000 Dec; 29(4):219-28. PubMed ID: 11170260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roles of p38- and c-jun NH2-terminal kinase-mediated pathways in 2-methoxyestradiol-induced p53 induction and apoptosis.
    Shimada K; Nakamura M; Ishida E; Kishi M; Konishi N
    Carcinogenesis; 2003 Jun; 24(6):1067-75. PubMed ID: 12807754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation.
    Kang MH; Wan Z; Kang YH; Sposto R; Reynolds CP
    J Natl Cancer Inst; 2008 Apr; 100(8):580-95. PubMed ID: 18398104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p38MAPK-Dependent sensitivity of Ewing's sarcoma family of tumors to fenretinide-induced cell death.
    Myatt SS; Redfern CP; Burchill SA
    Clin Cancer Res; 2005 Apr; 11(8):3136-48. PubMed ID: 15837770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenethyl isothiocyanate-induced apoptosis in p53-deficient PC-3 human prostate cancer cell line is mediated by extracellular signal-regulated kinases.
    Xiao D; Singh SV
    Cancer Res; 2002 Jul; 62(13):3615-9. PubMed ID: 12097262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
    Yang R; Piperdi S; Gorlick R
    Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of arachidonate 5-lipoxygenase triggers prostate cancer cell death through rapid activation of c-Jun N-terminal kinase.
    Ghosh J
    Biochem Biophys Res Commun; 2003 Jul; 307(2):342-9. PubMed ID: 12859962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Signaling pathways involved in induction of GADD45 gene expression and apoptosis by troglitazone in human MCF-7 breast carcinoma cells.
    Yin F; Bruemmer D; Blaschke F; Hsueh WA; Law RE; Herle AJ
    Oncogene; 2004 Jun; 23(26):4614-23. PubMed ID: 15064713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of MAP kinases and their cross-talk in TGF-beta1-induced apoptosis in FaO rat hepatoma cell line.
    Park HJ; Kim BC; Kim SJ; Choi KS
    Hepatology; 2002 Jun; 35(6):1360-71. PubMed ID: 12029621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
    Maeda H; Hori S; Nishitoh H; Ichijo H; Ogawa O; Kakehi Y; Kakizuka A
    Cancer Res; 2001 Jul; 61(14):5432-40. PubMed ID: 11454688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ajoene-induced cell death in human promyeloleukemic cells does not require JNK but is amplified by the inhibition of ERK.
    Antlsperger DS; Dirsch VM; Ferreira D; Su JL; Kuo ML; Vollmar AM
    Oncogene; 2003 Jan; 22(4):582-9. PubMed ID: 12555071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Essential role of mitogen-activated protein kinase pathway and c-Jun induction in epidermal growth factor-induced gene expression of human 12-lipoxygenase.
    Chen BK; Kung HC; Tsai TY; Chang WC
    Mol Pharmacol; 2000 Jan; 57(1):153-61. PubMed ID: 10617690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. JNK and ERK mitogen-activated protein kinases mediate THDA-induced apoptosis in K562 cells.
    Yang SH; Wu ZZ; Chien CM; Lo YH; Wu MJ; Chang LS; Lin SR
    Cell Biol Toxicol; 2008 Aug; 24(4):291-302. PubMed ID: 17934787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Norcantharidin-induced apoptosis is via the extracellular signal-regulated kinase and c-Jun-NH2-terminal kinase signaling pathways in human hepatoma HepG2 cells.
    Chen YN; Cheng CC; Chen JC; Tsauer W; Hsu SL
    Br J Pharmacol; 2003 Oct; 140(3):461-70. PubMed ID: 12970086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A dominant role for the c-Jun NH2-terminal kinase in oncogenic ras-induced morphologic transformation of human lung carcinoma cells.
    Xiao L; Lang W
    Cancer Res; 2000 Jan; 60(2):400-8. PubMed ID: 10667594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Docetaxel-induced apoptosis of human melanoma is mediated by activation of c-Jun NH2-terminal kinase and inhibited by the mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway.
    Mhaidat NM; Zhang XD; Jiang CC; Hersey P
    Clin Cancer Res; 2007 Feb; 13(4):1308-14. PubMed ID: 17317842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of ADP-ribosylation factor 4 as a suppressor of N-(4-hydroxyphenyl)retinamide-induced cell death.
    Woo IS; Eun SY; Jang HS; Kang ES; Kim GH; Kim HJ; Lee JH; Chang KC; Kim JH; Han CW; Seo HG
    Cancer Lett; 2009 Apr; 276(1):53-60. PubMed ID: 19041174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.